Search - tctmd.com

Displaying 161 - 180 of 351

Sort: Relevancy | Date

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Michael O'Riordan

August 25, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

L.A. McKeown

May 28, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

Advertisement

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Just One-Third of European Patients Get to LDL Cholesterol Goals

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Could Statins Curb Fatal or Severe COVID-19? Some Clues

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content